Reason: Brachytherapy planning History: Brachytherapy planning PELVIS:UTERUS, ADNEXA: Cervical mass compatible with patient's history of cervical cancer has ill-defined margins although grossly has decreased in size. It measures approximately 1.8 x 2.8 x 3.6 cm (series 601 image 28, series 901 image 19), previously 3.4 x 5.3 x 4.6 cm. Enhancement is decreased compared to prior, likely reflecting treatment response. Previously noted area of loss of fat plane between the mass and the rectum is less appreciated, although the mass remains close in proximity to the rectum. Previously noted loss of fat plane between the mass and the left pelvic side wall is again appreciated. Uterine fibroids have not significantly changed. Nabothian cysts again noted.BLADDER: Interval removal of Foley catheter.LYMPH NODES: Pelvic sidewall lymphadenopathy has since decreased compared to prior. Previous reference right pelvic sidewall lymph node measures 1.6 x 0.8 cm (series 701 image 29), previously 2.6 x 1.7 cm. Previous reference left pelvic sidewall rounded lymph node has also decreased in size (series 701 image 31).BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: Large left renal cyst extending into the pelvis, partially visualized.
1.Interval decrease in size of cervical mass with close proximity to the rectum and left pelvic side wall. 2.Interval decrease in size of bilateral pelvic side wall lymphadenopathy. 